Skip to content

A Cohort study on the efficacy and safety of Rubus suavissimus S. Lee in type 2 diabetes and prediabetes population

A Cohort study on the efficacy and safety of Rubus suavissimus S. Lee in type 2 diabetes and prediabetes population

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052596
Enrollment
Unknown
Registered
2021-11-02
Start date
2021-05-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

sweet tea group:Drinking sweet tea (1000ml) every day
Control group:Nil

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. The resident population of Dadi Village; 3. Voluntarily participate in the study and sign informed consent; 4. People with type 2 diabetes or prediabetes.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes mellitus; 2. Patients with poor blood glucose control (HbA1c>=9); 3. Pregnanancy and lactation; 4. Special types of diabetes; 5. Acute or chronic renal insufficiency; 6. Acute hepatitis, cirrhosis, liver failure; 7. Severe gastrointestinal dysfunction and gastrointestinal surgery; 8. Hyperglycemia caused by endocrine diseases, such as Cushing's syndrome, hyperthyroidism, pheochromocytoma, etc. 9. Immune system diseases; 10. Cardiovascular and cerebrovascular accidents in the last 3 months; 11. Acute infection; 12. A history of trauma and surgery within the last 2 weeks; 13. Malignant tumor; 14. Long-term use of hormones; 15. Long-term tea consumption; 16. Long-term use of Traditional Chinese medicine, health care products; 17. Unable to move, or uncooperative.

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin;

Secondary

MeasureTime frame
blood glucose;insulin;C-Peptide;

Countries

China

Contacts

Public ContactHoude Zhou

The Second Xiangya Hospital of Central South University

houdezhou@csu.edu.cn+86 731 85292223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026